REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,459,131 | -38.4% | 729,097 | -9.8% | 0.38% | -40.4% |
| Q3 2022 | $21,834,000 | +176.0% | 808,671 | +41.2% | 0.63% | +155.6% |
| Q2 2022 | $7,912,000 | +195.0% | 572,514 | +316.3% | 0.25% | +359.3% |
| Q1 2022 | $2,682,000 | +66.8% | 137,514 | +108.9% | 0.05% | +107.7% |
| Q2 2020 | $1,608,000 | -88.3% | 65,839 | -92.9% | 0.03% | -92.7% |
| Q1 2020 | $13,690,000 | +2.8% | 925,000 | +12.8% | 0.36% | +35.2% |
| Q4 2019 | $13,315,000 | -30.2% | 820,377 | +32.5% | 0.26% | -50.6% |
| Q1 2018 | $19,064,000 | +33.3% | 618,957 | +54.7% | 0.53% | +12.7% |
| Q4 2017 | $14,300,000 | – | 400,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |